2010
DOI: 10.1128/jcm.00954-09
|View full text |Cite
|
Sign up to set email alerts
|

First Detection of an Invasive Staphylococcus aureus Strain (D958) with Reduced Susceptibility to Glycopeptides in Saudi Arabia

Abstract: Strain D958, a methicillin-resistant Staphylococcus aureus strain with reduced susceptibility to vancomycin, was isolated from a 69-year-old Saudi male patient presenting with severe sepsis immediately after admission. Despite high serum levels of vancomycin, the same S. aureus strain was isolated from five blood culture sets during 1 week. Treatment failure under therapeutic levels of vancomycin prompted us to investigate the resistance profile of this strain in further detail. The MIC values for vancomycin a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 62 publications
0
18
0
Order By: Relevance
“…Strain MRGR3 belongs to a different clonal family (sequence type 239 [ST239], clonal complex 5 [CC5]) than strains ISP794 and RA1 (ST8) (1).…”
Section: Methodsmentioning
confidence: 99%
“…Strain MRGR3 belongs to a different clonal family (sequence type 239 [ST239], clonal complex 5 [CC5]) than strains ISP794 and RA1 (ST8) (1).…”
Section: Methodsmentioning
confidence: 99%
“…Since their first description in Japan in 1997, GISA and hGISA have been progressively reported worldwide [5,[8][9][10]. These strains have been previously associated with prolonged antibiotic therapy, prolonged hospitalization, treatment failure, increased mortality and epidemic episodes with cross-contamination between patients [11].…”
Section: Discussionmentioning
confidence: 99%
“…Failure with empiric vancomycin treatment in a Saudi 69-year-old male patient, for example, prompted physicians to obtain more accurate susceptibility data on the pathogen isolated from blood. This led to the discovery of the first heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA), a threatening signal to the effectiveness of empiric vancomycin treatment in hospitalized patients with severe infections [37].…”
Section: Overview Of Testing Methodologymentioning
confidence: 99%